On the origin of sensory impairment and altered pain perception in Prader-Willi syndrome: A neurophysiological study

European Journal of Pain

Volumn 13, Issue 8, 2009, Pages 829-835

  Priano, Lorenzo ^a,b   Miscio, Giacinta ^a   Grugni, Graziano ^a   Milano, Eva ^a   Baudo, Silvia ^a   Sellitti, Luigi ^a   Picconi, Roberto ^a   Mauro, Alessandro ^a,b  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Insulin resistance; Obesity; Pain; Prader Willi; Sensory thresholds

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARM; ARTICLE; BODY MASS; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; COLD SENSATION; CONTROLLED STUDY; ELECTRONEUROGRAPHY; EVOKED SOMATOSENSORY RESPONSE; FEMALE; GLUCOSE BLOOD LEVEL; HEAT SENSATION; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LEG; MALE; MOTOR NERVE CONDUCTION; NEUROPHYSIOLOGY; NOCICEPTION; OBESITY; PATHOGENESIS; PERCEPTIVE THRESHOLD; PERIPHERAL NERVOUS SYSTEM; PLANTARIS MUSCLE; PRADER WILLI SYNDROME; PRIORITY JOURNAL; SENSORY DYSFUNCTION; SENSORY NERVE CONDUCTION; SENSORY SYSTEM; SYMPATHETIC TONE; VIBRATION SENSE;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; COLD TEMPERATURE; ELECTRODIAGNOSIS; EVOKED POTENTIALS, SOMATOSENSORY; FEMALE; HOT TEMPERATURE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; PAIN; PAIN THRESHOLD; PERCEPTION; PRADER-WILLI SYNDROME; SENSATION DISORDERS; SYMPATHETIC NERVOUS SYSTEM; YOUNG ADULT;

EID: 68049087601     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2008.09.011     Document Type: Article

References (65)

1. Abbasi F., and Reaven G.M. Evaluation of the quantitative insulin sensitivity check index as an estimate of insulin sensitivity in humans. Metabolism 51 2 (2002) 235-237
2. Akefeldt A., Ekman R., Gillberg C., and Manson J.E. Cerebrospinal fluid monoamines in Prader-Willi syndrome. Biol Psychiatry 44 (1998) 1321-1328
3. Aizawa T., Maruyama K., Kondo H., and Yoshikawa K. Expression of necdin, an embryonal carcinoma-derived nuclear protein, in developing mouse brain. Brain Res Dev Brain Res 68 2 (1992) 265-274
4. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 2003;26(S1):S21-S24.
5. Brambilla P., Bosio L., Manzoni P., Pietrobelli A., Beccaria L., and Chiumello G. Peculiar body composition in patients with Prader-Labhart-Willi syndrome. Am J Clin Nutr (1997) 1369-1374
6. Brandt B.R., and Rosen I. Impaired peripheral somatosensory function in children with Prader-Willi syndrome. Neuropediatrics 29 3 (1998) 124-126
7. Burman P.E., Ritzen M., and Lindgren C. Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. [Review]. Endocr Rev 22 6 (2001) 787-799
8. Buschbacher R.M. Body mass index effect on common nerve conduction study measurements. Muscle Nerve 21 (1998) 1398-1404
9. Butler M.G., Bittel D., and Talebizadeh Z. Prader-Willi syndrome and a deletion/duplication within the 15q11-q13 region. J Med Genet 39 3 (2002) 202-204
10. Casey K.L., Minoshima S., Berger K.L., Koeppe R.A., Morrow T.J., and Frey K.A. Positron emission tomography analysis of cerebral structures activated specifically by repetitive noxious heat stimuli. J Neurophysiol 71 (1994) 802-807
11. Cassidy S.B., Forsythe M., Heeger S., Nicholls R.D., Schork N., Benn P., and Schwartz S. Comparison of phenotype between patients with Prader-Willi syndrome due to deletion 15q and uniparental disomy 15. Am J Med Genet 68 (1997) 433-440
12. Chong P.S., and Cros D.P. Technology literature review: quantitative sensory testing. Muscle Nerve 29 5 (2004) 734-747
13. Civardi C., Vicentini R., Grugni G., and Cantello R. Corticospinal physiology in patients with Prader-Willi syndrome: a transcranial magnetic stimulation study. Arch Neurol 61 10 (2004) 1585-1589
14. Conceição I.M., Castro J.F., Scotto M., and de Carvalho M. Neurophysiological markers in familial amyloid polyneuropathy patients: early changes. Clin Neurophysiol 119 (2008) 1082-1087
15. Davis K.D., Hutchison W.D., Lozano A.M., and Dostrovsky J.O. Altered pain and temperature perception following cingulotomy and capsulotomy in a patient with schizoaffective disorder. Pain 59 2 (1994) 189-199
16. Davis K.D., Taylor S.J., Crawley A.P., Wood M.L., and Mikulis D.J. Functional MRI of pain- and attention-related activations in the human cingulated cortex. J Neurophysiol 77 (1997) 3370-3380
17. Delisa J.A., MacKenzie K., and Baran E.M. Manual of nerve conduction velocity and somatosensory evoked potentials. 2nd ed. (1987), Raven Press, New York
18. Dimitropoulos A., Feurer I.D., Roof E., Stone W., Butler M.G., Sutcliffe J., et al. Appetitive behaviour, compulsivity, and neurochemistry in Prader-Willi syndrome. Ment Retard Dev Disabil Res Rev 6 (2000) 125-130
19. Dorfman L.J., and Robinson L.R. AAEM minimonograph: normative data in electrodiagnostic medicine. Muscle Nerve 20 (1997) 4-14
20. Doubell T.P., Mannion R.J., and Woolf C.J. The dorsal horn: state dependent processing, plasticity and the generation of pain. In: Wall P.D., and Melzack R. (Eds). Textbook of pain (1999), Churchill Livingstone, London, New York
21. Dumitru D. Nerve conduction studies. In: Dumitru D. (Ed). Electrodiagnostic medicine (1995), Hanley and Belfus, Philadelphia
22. Dyck P.J., Karnes J., O'Brien P.C., and Zimmerman I.R. Detection thresholds of cutaneous sensation in humans. In: Dyck P.D. (Ed). Peripheral neuropathy (1993), WB Saunders Co. 706-728
23. Ebert M.H., Schmidt D.E., Thompson T., and Butler M.G. Elevated plasma gamma-aminobutyric acid (GABA) levels in individuals with either Prader-Willi syndrome or Angelman syndrome. J Neuropsychiatry Clin Neurosci 9 (1997) 75-80
24. Folstein M.F., Folstein S.E., and McHugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 3 (1975) 189-198
25. Gerard M., Hernandez L., Wevrick R., and Stewart C.L. Disruption of the mouse necdin gene results in early post-natal lethality. Nat Genet 23 2 (1999) 199-202
26. Hall D.M., and Smith D.W. Prader-Willi syndrome. J Pediatr 81 (1972) 286-293
27. Hilz M.J., and Dütsch M. Quantitative studies of autonomic function. Muscle Nerve 33 (2006) 6-20
28. Holm V.A., Cassidy S.B., Butler M.G., Hanchett J.M., Greenswag L.R., Whitman B.Y., et al. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 91 (1993) 398-402
29. Jay P., Rougeulle C., Massacrier A., Moncla A., Mattei M.G., Malzac P., et al. The human necdin gene, NDN, is maternally imprinted and located in the Prader-Willi syndrome chromosomal region. Nat Genet 17 (1997) 357-361
30. Khan N.L., and Wood N.W. Prader-Willi and Angelman syndrome: update on genetic mechanisms and diagnostic complexities. Curr Opin Neurol 12 (1999) 149-154
31. Katz A., Nambi S.S., Mather K., Baron A.D., Follman D.A., Sullivan G., et al. Quantitative insulin-sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85 (2000) 2402-2410
32. Kuwako K., Hosokawa A., Nishimura I., Uetsuki T., Yamada M., Nada S., et al. Disruption of the paternal necdin gene diminishes TrkA signaling for sensory neuron survival. J Neurosci 25/30 (2005) 7090-7099
33. Laurance B.M. Prader-Willi syndrome. Pediatr Res Commun 7 (1993) 77-91
34. Lawson S.N. Phenotype and function of somatic primary afferent nociceptive neurons with C-, Aδ or Aa/ß-fibres. Exp Physiol 87 2 (2002) 239-244
35. Lucignani G., Panzacchi A., Bosio L., Moresco R.M., Ravasi L., Coppa I., et al. GABAa receptor abnormalities in Prader-Willi syndrome assessed with positron emission tomography and [11C] flumazenil. Neuroimage 22 (2004) 22-28
36. Meaney F.J., and Butler M.G. The developing role of anthropologists in medical genetics: anthropometric assessment of the Prader-Labhart-Willi syndrome as an illustration. Med Anthropol 10 4 (1989) 247-253
37. Miller L., Angulo M., Price D., and Taneja S. MR of the pituitary in patients with Prader-Willi syndrome: size determinations and imaging findings. Pediatr Radiol 26 (1996) 43-47
38. Miscio G., Guastamacchia G., Brunani A., Priano L., Baudo S., and Mauro A. Obesity and peripheral neuropathy risk: a dangerous liaison. J Peripher Nerv Syst 10 4 (2005) 354-358
39. Muscatelli F., Abrous D.N., Massacrier A., Boccaccio I., Le Moal M., and Cau P. Cremer H disruption of the mouse necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader-Willi syndrome. Hum Mol Genet 9 20 (2000) 3101-3110
40. Nakada Y., Taniura H., Uetsuki T., Inazawa J., and Yoshikawa K. The human chromosomal gene for necdin, a neuronal growth suppressor, in the Prader-Willi syndrome deletion region. Gene 213 1-2 (1998) 65-72
41. Nativio D.G. The genetics, diagnosis, and management of Prader-Willi syndrome. J Pediatr Health Care 16 (2002) 298-303
42. Nicholls R.D. Genomic imprinting candidate genes in the Prader-Willi and Angelman syndromes. Curr Opin Genet Dev 3 (1993) 445-456
43. Novella S.P., Inzucchi S.E., and Goldstein J.M. The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve 24 (2001) 1229-1231
44. Peters A.L. The clinical implications of insulin resistance. Am J Manag Care 6 S13 (2000) S668-S674
45. Prader A., Labhart A., and Willi H. Ein syndrom von adipositas, kleinwuchs, kryptorchismus und oligofrenic nach myalonieartigen zustand im neugeborenenalter. Schweiz Med Wochenschr 86 (1956) 1260-1261
46. Rolke R., Magerl W., Andrews Campbell K., Schalber C., Caspari S., Birklein F., et al. Quantitative sensory testing: a comprehensive protocol for clinical trials. Eur J Pain 10 (2006) 77-88
47. Rolke R., Baron R., Maier C., Tölle T.R., Treede R.D., Beyer A., et al. Quantitative sensory testing in the german research network on neuropathic pain (DFNS): standardized protocol and reference values. Pain 123 (2006) 231-243
48. Roy M.S., Milot J.A., Polomeno R.C., and Barsoum-Homsy M. Ocular findings and visual evoked potential response in the Prader-Willi syndrome. Can J Ophthalmol 27 (1992) 307-312
49. Schmidt H., Bechtold S., and Schwarz H.P. Prader-Labhart-Willi syndrome: auxological response to a conventional dose of growth hormone in patients with classical growth hormone deficiency. Eur J Med Res 5 (2000) 307-310
50. Schoeller D.A., Levitsky L.L., Bandibi L.G., Dietz W.W., and Walczak A. Energy expenditure and body composition in Prader-Willi syndrome. Metabolism 37 (1988) 115-120
51. Shahani B.T., Day T.J., Cros D., Khalil N., and Kneebone C.S. RR interval variation and the sympathetic skin response in the assessment of autonomic function in peripheral neuropathy. Arch Neurol 47 (1990) 659-664
52. Shy M.E., Frohman E.M., So Y.T., Arezzo J.C., Cornblath D.R., Giuliani M.J., et al. Quantitative sensory testing: report of the therapeutics and technology assessment subcommittee of the American academy of neurology. Neurology 60 6 (2003) 898-904
53. Siao P., and Cros D.P. Quantitative sensory testing. Phys Med Rehabil Clin N Am 14 (2003) 261-286
54. Stauder J.E.A., Brinkman M.J.R., and Curfs L.M.G. Multi-modal P3 deflation of event-related brain activity in Prader-Willi syndrome. Neurosci Lett 327 (2002) 99-102
55. Swaab D.F., Purba J.S., and Hofman M.A. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. J Clin Endocrinol Metab 80 2 (1995) 573-579 Feb
56. Takazaki R., Nishimura I., and Yoshikawa K. Necdin is required for terminal differentiation and survival of primary dorsal root ganglion neurons. Exp Cell Res 277 2 (2002) 220-232
57. Treede R.D., Kenshalo D.R., Gracely R.H., and Jones A.K. The cortical representation of pain. Pain 79 (1999) 105-111
58. Uetsuki T., Takagi K., Sugiura H., and Yoshikawa K. Structure and expression of the mouse necdin gene Identification of a postmitotic neuron-restrictive core promoter. J Biol Chem 271 2 (1996) 918-924
59. Ulvi H., Yoldaş T., Yiǧiter R., and Müngen B. R-R interval variation and the sympathetic skin response in the assessment of the autonomic nervous system in leprosy patients. Acta Neurol Scand 107 (2003) 42-49
60. Vetrugno R., Liguori R., Cortelli P., and Montagna P. Sympathetic skin response. Basic mechanisms and clinical applications. Clin Auton Res 13 (2003) 256-270
61. Vogels A., Van Den Ende J., Keymolen K., Mortier G., Devriendt K., Legius E., et al. Minimum prevalence, birth incidence and cause of death for Prader-Willi syndrome in Flanders. Eur J Hum Genet 12 3 (2004) 238-240
62. Wagstaff J., Knoll J.H., Fleming J., Kirkness E.F., Martin-Gallardo A., Greenberg F., et al. Localization of gene encoding the GABA-A receptor beta-3 subunit to the Angelman/Prader-Willi region of human chromosome 15. Am J Hum Genet 49 (1991) 330-337
63. Wechsler D. WAIS-R manual. In: Wechsler D. (Ed) (1981), Psychological Corporation, New York
64. Williams M.S., Rooney B.L., Williams J., Josephson K., and Pauli R. Investigation of thermoregulatory characteristics in patients with Prader-Willi syndrome. Am J Med Genet 49 3 (1994) 302-307
65. Wollmann H.A., Schultz U., Grauer M.L., and Ranke M.B. Reference values for height and weight in Prader-Willi syndrome based on 315 patients. Eur J Pediatr 157 (1998) 634-642